Malignant mixed Müllerian tumors of the uterus

Int J Gynaecol Obstet. 1994 Oct;47(1):39-44. doi: 10.1016/0020-7292(94)90459-6.

Abstract

Objective: To review the prognostic factors of Chinese women with mixed Müllerian tumors of the uterus.

Method: A retrospective review of 21 cases of malignant mixed Müllerian tumors of the uterus treated during the 10-year period from 1980 to 1990.

Results: All patients except one were postmenopausal. The incidence of previous pelvic irradiation was 9.5%. The most common presenting symptom was abnormal vaginal bleeding. One-third of patients yielded an abnormal cervical smear. Treatment included surgery, chemotherapy and radiotherapy in the majority of patients. Prognosis was poor with only three long-term survivors, all with stage-I homologous tumors with superficial myometrial invasion. The survival rate for stage-I and -II disease at 2 years was 50% and for more advanced disease extending beyond the uterus was 0%. The survival rate for all stages at 5 years was 14.3%, and the cumulative probability of survival at 5 years was 0.165.

Conclusion: The most important prognostic factors appear to be the extent of tumor involvement at the time of diagnosis and the depth of myometrial invasion.

MeSH terms

  • Combined Modality Therapy
  • Female
  • Hong Kong / epidemiology
  • Humans
  • Life Tables
  • Middle Aged
  • Mixed Tumor, Mullerian / mortality*
  • Mixed Tumor, Mullerian / therapy
  • Prognosis
  • Retrospective Studies
  • Survival Analysis
  • Survival Rate
  • Uterine Neoplasms / mortality*
  • Uterine Neoplasms / therapy